Filing Details
- Accession Number:
- 0001651844-19-000023
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-12 14:07:25
- Reporting Period:
- 2019-07-10
- Accepted Time:
- 2019-07-12 14:07:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1018735 | Nymox Pharmaceutical Corp | NYMX | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1651844 | George James Robinson | 10 East Lee Street Suite 2705 Baltimore MD 21202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-10 | 5,834 | $1.73 | 3,509,384 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-10 | 300 | $1.73 | 3,509,684 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-10 | 600 | $1.72 | 3,510,284 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-10 | 166 | $1.73 | 3,510,450 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-10 | 100 | $1.72 | 3,510,550 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |